We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appeals Court Upholds FDA’s Rejection of Opioid-Deterrent Drug
Appeals Court Upholds FDA’s Rejection of Opioid-Deterrent Drug
A Federal appeals court has upheld the FDA’s denial of a new drug application for an abuse-deterrent formulation of oxycodone from Pharmaceutical Manufacturing Research Services (PMRS).